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 13 
Terpenes constitute the largest class of natural products and serve as an important source for 14 
medicinal treatments. Despite constant progress in chemical synthesis, the construction of complex 15 
polycyclic sesqui- and diterpene scaffolds remains challenging. Natural cyclase enzymes, however, are 16 
able to form the whole variety of terpene structures from just a handful of linear precursors. Man-17 
made catalysts able to mimic such natural enzymes are lacking. Here, we describe the examples of 18 
sesquiterpene cyclisations inside an enzyme-mimicking supramolecular catalyst. This strategy allowed 19 
the formation of the tricyclic sesquiterpene isolongifolene in only four steps. The mechanism of the 20 
catalysed cyclisation reaction was elucidated using 13C-labelling studies and DFT calculations. 21 
 22 
For decades, terpene natural products have been popular target compounds for total synthesis due to 23 
their biological functions and medicinal applications.1, 2 The syntheses of complex polycyclic sesqui- 24 
and diterpene skeletons routinely involve long linear sequences. Although step count is only one way 25 
to evaluate a synthetic route, a long synthetic route generally suffers from two main disadvantages: 26 
(1) A large effort in manpower is required and (2) the final yields of the natural products are usually 27 
low. For instance, in the shortest total synthesis of the sesquiterpene isolongifolene (A),3, 4 six steps 28 
were required to assemble the intermediate 2 containing all necessary carbon atoms, which was 29 
converted to isolongifolene in another four steps. Similarly, in the shortest synthesis of longifolene 30 
(5),5 an initial four-step sequence smoothly introduced the majority of the required carbon atoms. 31 
However, another seven steps were required for the completion of the longifolene skeleton. In 32 
contrast, nature utilizes a fundamentally different approach to access cyclic terpenes like longifolene 33 
and isolongifolene. The simple linear substrate farnesyl pyrophosphate 6 is cyclised by an enzyme, 34 
termed terpene cyclase, to directly produce the framework of longifolene.6 Longifolene is known to 35 
undergo facile acid-catalysed rearrangement to form isolongifolene.7, 8 A related mechanism could also 36 
be operational in natural enzymes. Isolongifolene has long been known to exist in some liverworts,9 37 
but its biosynthesis has not been elucidated yet (Figure 1). 38 
 39 
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Figure 1. Comparison of the total synthesis and the biosynthesis6 of isolongifolene3, 4 and longifolene5. 2 
In the total syntheses, long synthetic sequences were required for the stepwise construction of the 3 
skeleton of isolongifolene and longifolene. In contrast, by utilizing linear farnesyl pyrophosphate as the 4 
substrate, the natural enzyme directly accesses longifolene via cyclisation-rearrangement cascade 5 
reaction. Acid-catalysed rearrangement reaction of longifolene is known to produce isolongifolene. 6 
However, the biosynthesis of isolongifolene is unknown. 7 
Fascinated by nature’s elegance and high efficiency, synthetic organic chemists have strived to mimic 8 
the biosynthesis of terpene natural products. Generally, the biosynthesis of terpenes occurs via two 9 
reaction pathways, which differ in the mechanism of the substrate activation. The head-to-tail (HT) 10 
terpene10 cyclisation is initiated via electrophilic activation at the prenyl end (head) of the substrate, 11 
which subsequently cyclises via a concerted mechanism. This class of cyclisation has been already 12 
extensively reproduced in bulk solution and applied to total synthesis.11 However, the HT terpene 13 
cyclisation only produces very limited structural variety, which in the case of sesquiterpenes is limited 14 
to decalin frameworks. A much larger structural variety is produced by the so-called tail-to-head (TH) 15 
terpene10 cyclisation. In this cyclisation type, the reaction is initiated by the formation of an allylic 16 
cation via the cleavage of the pyrophosphate group at the tail end of the acyclic terpene. Biomimetic 17 
TH terpene cyclisations employing man-made catalysts are challenging. There are a few literature 18 
examples describing the formation of polycyclic sesquiterpene structures in bulk solution by employing 19 
strong Brønsted or Lewis acids.12-16 Such strategies rely mainly on the iterative protonation of the 20 
formed monocyclic intermediates, and are low yielding and unselective. One example of a selective 21 
sesquiterpene cyclisation was reported by the Shenvi research group. Utilizing an unnaturally modified 22 
terpene precursor and stoichiometric amounts of aluminium Lewis acids, they were able to construct 23 
the highly strained funebrene skeleton.10 One major obstacle in the reproduction of TH terpene 24 
cyclisation using man-made catalysts is the instability of the highly reactive cationic intermediates 25 
involved in the reaction cascade, which are susceptible to exogenous nucleophiles or elimination 26 
reactions. Natural terpene cyclases circumvent this issue by enclosing the substrate within the 27 
enzymatic pocket and by stabilizing key carbocations with precisely positioned aromatic residues.17 28 
Even more importantly, the uptake into the enzyme pocket facilitates the control over the substrate 29 
conformation. This conformation is then efficiently translated into the product and enables nature to 30 
produce the wide variety of structures with high fidelity. Regular Lewis or Brønsted acid catalysts 31 
inherently lack the ability to influence the flexible terpene precursor in a meaningful way. We reasoned 32 
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that complex terpene cyclase enzymes may be mimicked by much simpler aromatic supramolecular 1 
capsules. Such systems were increasingly investigated as simple enzyme mimetics during the last 2 
decade.18-28 The hexameric resorcinarene capsule I, originally disclosed by the Atwood group in 1997,29 3 
was identified by us30 and the groups of Scarso and Strukul31 as a supramolecular enzyme-like catalyst. 4 
Based on hydrogen-bond interactions, capsule I self-assembles from six resorcinarene monomers 7 5 
and eight water molecules in apolar solvents to enclose an internal volume of approximately 1.4 nm3. 6 
Importantly, capsule I is known to stabilize cationic guests inside its confinement via cation-π 7 
interactions.32, 33 Recently, we reported that the resorcinarene capsule serves as an efficient catalyst 8 
for the TH cyclisation of monoterpenes.34, 35 The relatively selective cyclisation of geranyl acetate (8) to 9 
α-terpinene (11) is noteworthy (Figure 2). The preference for α-terpinene as the sole major product 10 
relies on the full propagation of the positive charge along the reaction pathways, which is likely due to 11 
the stabilisation of the cationic intermediates (for instance 9 and 10) by the capsule. This preliminary 12 
result encouraged us to probe the cyclisation of more complex substrates. Molecular modelling 13 
indicated that the precursor of cyclic sesquiterpenes, farnesol, easily fits the cavity of capsule I.  14 
Here we report the biomimetic TH cyclisation of sesquiterpenes with I as the supramolecular catalyst. 15 
Using cyclisation precursors related to those of natural enzymes, capsule-catalysed cyclisations enable 16 
direct access to several bicyclic and tricyclic sesquiterpene natural products. Stabilisation of reaction 17 
intermediates was attributed to the encapsulation of the substrate into the cavity of the catalyst. 18 
Control on the substrate conformation was achieved by a combination of encapsulation and 19 
incorporating control elements into the substrate. In the case of the reaction of cyclofarnesyl acetate, 20 
the tricylic sesquiterpene isolongifolene was formed as the single main cyclisation product. This result 21 
raises new possibility for the efficient synthesis of terpene natural products. Additionally, the 22 
mechanism of the formation of isolongifolene was elucidated by 13C-labelling experiment and DFT-23 
calculation.  24 
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Figure 2. Selective cyclisation of the monoterpene geranyl acetate catalysed by the resorcinarene 27 
capsule. a, The resorcinarene monomers 7 self-assemble in apolar solvents with eight water molecules 28 
to form the hexameric capsule I with an internal volume of 1.4 nm3. The capsule is capable of 29 
stabilizing cationic species via cation-π interactions. b, The resorcinarene capsule was employed as an 30 
artificial terpene cyclase mimic for the cyclisation of monoterpenes. The cyclisation reactions were 31 
likely facilitated by the stabilisation of the cationic intermediates/transition states by the capsule. 32 
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Results 1 
Cyclisation of linear sesquiterpenes. We started our investigation by testing the commercially 2 
available (2E,6E)-farnesol (FOH) under the optimized reaction conditions for monoterpene cyclisations 3 
(10 mol% I and 3 mol% HCl as catalysts, 33.3 mM in chloroform, 30 ° C).35 According to gas 4 
chromatography (GC) analysis, complete conversion of the starting material was reached after 4d. 5 
Subsequent analysis of the product mixture with 1H and 13C NMR spectroscopy (Supplementary Figure 6 
9 and 10) and comparison with literature data (Supplementary Table 1 and 2), revealed the formation 7 
of polycyclic products (Figure 3a), including 2-epi-α-cedrene (B), α-cedrene (C), ɛ-patchoulene (D), δ-8 
selinene (E) and 10-epi-zonarene (F).  9 
The cyclisation conditions rely on catalytic amounts of capsule I and hydrochloric acid (HCl). To clarify 10 
if HCl alone could activate the substrate and promote the cyclisation reaction outside the capsule, a 11 
series of control experiments were performed. First, running the reaction without capsule I failed to 12 
effect any detectable formation of products under otherwise identical conditions. The same was true 13 
when omitting the catalytic amounts of HCl. Formation of cyclic products was only detected in the 14 
presence of catalytic amount of capsule I (10 mol%) and HCl (3 mol%). Third, when the capsule was 15 
blocked with a strongly binding inhibitor (1.5 eq nBu4NBr) in the presence of HCl, the cyclisation 16 
products were formed only in trace amounts (<0.22%, compare Supplementary Table 5 and 6). 17 
Additionally, 1H NMR studies clearly indicated that the cyclisation precursor is encapsulated to some 18 
extent, and is in slow exchange with the bulk solution (Supplementary Figure 11 and 12). Taken 19 
together, these results provided strong evidence that the cyclisation reactions indeed proceeded 20 
inside the confinement of the capsule. Furthermore, in line with our observations in the monoterpene 21 
cyclisation, the reaction relies on the synergistic interplay between both catalysts, capsule and HCl.35 22 
It was demonstrated in the monoterpene cyclisations catalysed by capsule I that the double bond 23 
geometry of the substrate has a major influence on the product selectivity.34, 35 Therefore, the other 24 
double bond isomers of farnesol were synthesized according to literature procedures36 and subjected 25 
to the cyclisation conditions. The use of the 2Z-substrates did not improve product selectivity. More 26 
promiscuous product mixtures were formed in the reaction of (2Z,6E)- and (2Z,6Z)-farnesol (Figure 3b 27 
and 3c). However, the (2E,6Z)-isomer displayed a markedly improved product selectivity (Figure 3d). 28 
All four substrates were also tested with acetate as the leaving group (Fig. 3e-h).34, 35 The most selective 29 
cyclisation was achieved by employing (2E,6Z)-farnesyl acetate (FOAc) (Figure 3h) as the substrate. δ-30 
Selinene (E) and 10-epi-zonarene (F) were formed as the main products in 18% and 10% yield, 31 
respectively (GC-yields, corrected by internal standard and response factors; Supplementary Table 3-32 
5). Although the yield of δ-selinene (18%) may appear modest at first, it is comparable to that of the 33 
natural δ-selinene synthase (25%).37 In contrast to the monoterpene cyclisation, where the variation 34 
of the leaving group dramatically changes the cyclisation outcome,35 the use of the acetate leaving 35 
group only slightly increased the product yields in the case of sesquiterpene cyclisations. This may 36 
indicate that the intramolecular attack of a π-bond on the transiently formed carbocation prevents the 37 
premature quenching of cationic intermediates by the cleaved leaving group. 38 
The formation of δ-selinene (E) is noteworthy. Mechanistically, it arises from an initial 1,10-cyclisation 39 
followed by a reaction cascade37 (Figure 3i and Supplementary Figure 13). The relatively useful yield 40 
(18%) of δ-selinene in the reaction of (2E,6Z)-FOAc obviously indicates the preference for this reaction 41 
pathway (Figure 3h). However, in the cyclisation of (2E,6E)-FOAc (Figure 3e), the selectivity for δ-42 
selinene is greatly attenuated. The preference for the 1,10-cyclisation in the case of (2E,6Z)-FOAc likely 43 
stems from the suitable substrate conformation caused by the 6Z-double bond. Intriguingly, the 44 
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formation of δ-selinene was not observed in the cyclisation reactions of (2Z,6E)- and (2Z,6Z)-FOAc 1 
(Figure 3f-g). This indicates that, with the substrates containing the 2Z-double bond moiety, the 2 
alternative 1,6-ring closure mechanism is operational. When comparing the GC-traces of all substrates, 3 
it is evident that the 1,10-cyclisation path ((2E,6Z)-FOAc, Figure 3h) displays higher product selectivity 4 
than the 1,6-pathway ((2Z,6E)-FOAc and (2Z,6Z)-FOAc, Figure 3f-g). In the former mechanism, a 5 
cyclodecadiene structure is formed as the first intermediate, whereas the 1,6-ring closure leads to the 6 
formation of a cyclohexene intermediate with a pendent octyl residue. It is likely that the higher strain 7 
in the cyclodecadiene intermediate limits its conformational freedom, which reduces the available 8 
reaction pathways and ultimately leads to higher selectivity. 9 
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Figure 3. Product analysis of the capsule-catalysed cyclisation reactions of farnesyl substrates. a-h, 1 
GC-traces of the cyclisation reaction of (2E,6E)-FOH, (2Z,6E)-FOH, (2Z,6Z)-FOH, (2E,6Z)-FOH, (2E,6E)-2 
FOAc, (2Z,6E)-FOAc, (2Z,6Z)-FOAc and (2E,6Z)-FOAc at full conversion of substrates. The intensity of 3 
the peaks in the GC-traces are normalized to an internal standard (For full spectra, see Supplementary 4 
Figure 1-8) i, the structures of the cyclisation precursors, the main cyclisation products and the 5 
proposed mechanism from (2E)-FOH/FOAc to δ–selinene (E). The double bond geometry in the 6 
substrate accounts for the different product selectivities observed. The higher selectivity of the 7 
cyclisation reaction of (2E,6Z)-FOAc is attributed to the conformational control of the substrate and 8 
the reaction intermediate. 9 
 10 
These results demonstrated that conformational control of the substrate and intermediates is required 11 
for good selectivity in the cyclisation reaction. As a long-term goal, we desire to effect this 12 
conformational control by utilizing less symmetric supramolecular containers as the catalysts. For the 13 
time being, however, we explored an alternative way to limit the conformational flexibility of the 14 
substrate: Incorporation of one ring into the cyclisation precursor.  15 
Cyclisation of monocyclic sesquiterpenes. The cyclofarnesyl substrates (Figure 4, grey box) were 16 
synthesized and investigated under the cyclisation conditions. Indeed, the reactions of the 17 
cyclofarnesyl alcohols (cycloFOH, Figure 4a and 4b) exhibited a higher degree of product selectivity 18 
than the corresponding acyclic farnesols. Moreover, the selectivity was further improved when the 19 
alcohol leaving group was replaced by an acetate moiety: A single major species was observed in the 20 
reactions of cyclofarnesyl acetates (cycloFOAc, Figure 4c and 4d). With the aid of GC-MS and NMR 21 
spectroscopy (Supplementary Figure 18-20), the major product (GC yield of 29% and 23% starting from 22 
(Z)- and (E)-cyclofarnesyl acetate, respectively; Supplementary Table 7 and 8) was identified to be the 23 
tricyclic sesquiterpene isolongifolene (A), a natural product that was found in some liverworts.9 24 
Cyclisations of related substrates were reported in the literature using chlorosulfonic and formic acid.38, 25 
39 Interestingly, the reactions in solution followed an alternative pathway (see discussion below).  26 
Mechanistic investigations. The formation of isolongifolene potentially follows a mechanism related 27 
to the biosynthesis of the monoterpene camphene40 (Figure 4e). Initially, a 1,6-cyclisation yields the 28 
spirocyclic intermediate 15. In the case of (2E)-cyclofarnesyl acetate (cycloFOAc), an isomerization of 29 
the allylic moiety has to occur prior to the cyclisation. This also explains the convergence of the 30 
reactivity from the E- and Z-isomers. Intermediate 15 undergoes a 3,7-ring closure that according to 31 
DFT calculations (see below) is concerted with a Wagner-Meerwein [1,2]-shift to form intermediate 16. 32 
From cation 16, two alternative pathways are conceivable. The first mechanism is more 33 
straightforward and involves a [1,2]-methyl shift, followed by proton elimination to yield compound 34 
ent-A. Alternatively, a sequence consisting of an [1,2]-alkyl shift, a 1,3-hydride shift and a second [1,2]-35 
alkyl shift (a concerted reaction according to DFT calculations, see below) would deliver cation 18. 36 
Intermediate 18 would then deliver isolongifolene (A) via methyl shift and proton elimination. 37 
Although the second possibility initially seemed unlikely, recent experimental work on the cyclisation 38 
mechanisms of the diterpenes cyclooctat-9-en-7-ol and tsukubadiene using isotopically labelled 39 
precursors resulted in the discovery of unexpected carbon backbone rearrangements.41, 42 This 40 
prompted us to experimentally differentiate between these two possibilities. For this purpose, the 41 
cyclisation of (2Z)-(1-13C)cyclofarnesyl acetate (20), synthesized based on a known route to labelled 42 
farnesols (Supplementary Method),43 was investigated. The more direct first mechanism would lead to 43 
the incorporation of the 13C-label at the methylene bridge. In contrast, the second mechanism would 44 
deliver the label at the ethylene bridge. Surprisingly, the isolongifolene formed contained the 13C-label 45 
exclusively on the ethylene bridge, ruling out the more direct route via ent-19 (Supplementary Figure 46 
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21-26). The reported cyclization studies of cyclofarnesyl derivatives in solution produced different 1 
products (Figure 4f).38, 39 An initial 2,7-ring closure and Wagner-Meerwein [1,2]-alkyl shift produced 2 
intermediate 23 that was either directly quenched by a nucleophile (product 24) or underwent a 1,3-3 
hydride shift to form product 26. The 3,7-ring closure pathway observed inside capsule I is only 4 
occurring to a very small extent and more importantly, the cation produced was immediately 5 
quenched by the nucleophile present to produce 27. It is evident that in solution cationic intermediates 6 
are much more susceptible to quenching by nucleophiles present. In addition, an alternative cyclization 7 
mechanism seems operational. 8 
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Figure 4. Product analysis of the capsule-catalysed cyclisation reactions of cyclofarnesyl substrates. 12 
a-d, GC-traces of the cyclisation reaction of (Z)-cycloFOH, (E)-cycloFOH, (Z)-cycloFOAc and (E)-13 
cycloFOAc at full conversion of the substrates. The intensities of the peaks in the GC-traces are 14 
normalized to an internal standard (For full spectra, see Supplementary Figure 14-17). e, The proposed 15 
mechanism for the biosynthesis of isolongifolene. f, Literature results for the cyclisation of 16 
cyclofarnesyl derivatives in solution utilizing chlorosulfonic acid or formic acid.38, 39  17 
To learn more about the mechanism operational inside capsule I, DFT-computations were performed 18 
(Supplementary Table 9). The reactions depicted in Figure 5 were calculated at the mPW1PW91/6-19 
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311+G(d,p)//B3LYP/6-311+G(d,p)-GD3BJ level of theory. The suitability of this computational method 1 
for carbocation rearrangements was demonstrated before.44, 45 The energy barrier for the cyclisation 2 
of 15 (i.e. the most stable conformer 15b) to 16 (TS1a, +9.1 kcal/mol) is favoured by 2.5 kcal/mol over 3 
an alternative cyclisation leading to ent-18 (TS1b, +11.6 kcal/mol). Cation 16 rearranges via a 4 
concerted 1,2-alkyl/1,3-hydride/1,2-alkyl shift sequence (TS2a, +4.9 kcal/mol) to 18. A subsequent 1,2-5 
Me-shift (TS3, -2.0 kcal/mol, shift of the exo-methyl group) rearranges 18 to the protonated 6 
isolongifolene 19, which exhibits the 13C-label on its ethylene bridge. An alternative rearrangement of 7 
16 (TS2b, +8.7 kcal/mol, shift of the endo-methyl group) yielding ent-19 with a 13C-labeled methylene 8 
group is prevented by a 3.8 kcal/mol higher barrier. This 3.8 kcal/mol higher barrier is due to the 9 
unfavourable endo-position of the 1,2-migrating methyl group in 16. In contrast, 18 exhibits the 1,2-10 
migrating methyl group in exo-position, resulting in a smooth 1,2-Me rearrangement via TS3 to 11 
produce 19 (Figure 5). 12 
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Figure 5. Computed energy profile for the formation of protonated isolongifolene 19. The reactions 15 
were calculated at the mPW1PW91/6-311+G(d,p)//B3LYP/6-311+G(d,p)-GD3BJ level of theory.44-46 In 16 
accordance with the result obtained from the 13C-labelling experiment, DFT calculation indicated that 17 
the reaction pathway involving the additional 1,3-hydride shift step (blue) is energetically favourable. 18 
The mechanism proposed may also be of relevance for the biosynthesis of isolongifolene. The acid-19 
catalysed rearrangement of the sesquiterpene natural product longifolene is known to generate 20 
isolongifolene as the major product.8 In principle, such a rearrangement could account for the 21 
biosynthetic origin of isolongifolene. The selective conversion of cyclofarnesyl acetate to 22 
isolongifolene catalysed by capsule I raises another mechanistic possibility which involves cyclofarnesyl 23 
pyrophosphate 21 as the key intermediate (see Figure 4e). Although 21 has not yet been described as 24 
naturally occurring, the cyclofarnesyl formate ester is a known natural product.47 A type II terpene 25 
cyclase48 may convert farnesyl pyrophosphate 6 to 21 via protonation on the distal double bond and 26 
nucleophilic attack of the internal double bond on the C11-position, followed by deprotonation at C6. 27 
Subsequently, the monocyclic intermediate 21 would be converted inside a type I terpene cyclase48 in 28 
analogy to the reaction observed in capsule I. Such a synergistic operation of type I and type II terpene 29 
cyclase enzymes is known for instance in the biosynthesis of the diterpene natural product abietadiene 30 
and other labdane related diterpenes.17, 49 31 
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Application in total synthesis. The selective cyclisation of cyclofarnesyl acetates also enables the 1 
shortest total synthesis of isolongifolene to date (Figure 6). Starting from the inexpensive bulk chemical 2 
dihydro-β-ionone (28), cyclofarnesyl acetate (cycloFOAc) was synthesized in a scalable three-step 3 
sequence. The capsule-catalysed cyclisation of cycloFOAc serves as the key step, which allows the 4 
formation/rearrangement of four C-C bonds (highlighted in grey in Figure 6) and the construction of 5 
two quaternary carbon centres (highlighted by dots) in one step. In total, racemic isolongifolene was 6 
synthesized in 11% overall yield (83% NMR purity, 85% GC purity, Supplementary Figure 27-30). This 7 
sequence provides isolongifolene (A) in only four steps and in preparatively useful yields (previously 8 
reported total syntheses: 10-19 steps).3, 50Although the isolongifolene obtained by separation using 9 
regular column chromatography is not analytically pure, it can serve as readily available material for 10 
further functionalization. Allylic oxidation of isolongifolene to the natural product isolongifolenone 11 
(29)51 facilitated the isolation as a pure compound. It was obtained in 13% isolated yield from 28 12 
(Supplementary Figure 31). 13 
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Figure 6. Short synthesis of isolongifolene and isolongifolenone. a, Online price quote from Sigma 16 
Aldrich. Starting from Dihydro-ß-ionone, isolongifolene was synthesized in a scalable four-step 17 
sequence involving the capsule-catalysed TH terpene cyclisation as the key step. The minor impurities 18 
contained in the isolated isolongifolene could be completely eliminated after an allylic oxidation 19 
reaction, yielding the natural product isolongifolenone as an analytically pure compound.  20 
Conclusions 21 
We report examples of a selective tail-to-head sesquiterpene cyclisation catalysed by an artificial 22 
enzyme mimic. In nature, the control over the conformation of farnesyl pyrophosphate is known to be 23 
a critical determinant for the ultimate product specificity.17 In this study, this was achieved by a 24 
combination of encapsulating the substrate into the confined molecular capsule and incorporating 25 
control elements (Z-double bond, cyclohexene ring) into the substrate structure. The capsule-catalysed 26 
cyclisation reactions may serve as a promising tool for the efficient construction of complex terpene 27 
natural products in the future. As a first proof of principle, a four-step synthesis of the complex tricyclic 28 
sesquiterpene natural product isolongifolene was achieved by using a biomimetic TH terpene 29 
cyclisation as the key step. The mechanism of the cyclisation/rearrangement cascade was elucidated 30 
through 13C-labelling experiments and DFT calculations. The proposed mechanism indicated that 31 
cyclofarnesyl pyrophosphate potentially could serve as a key intermediate in the biosynthesis of 32 
isolongifolene. In the future, we aim at achieving more efficient control of the substrate conformation 33 
inside supramolecular capsules by tailoring the cavity shape. To this end, efforts will be devoted to 34 
modification of the present system or developing new catalysts, which are better suited to influence 35 
the conformation of the bound substrate. 36 
 37 
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Methods 1 
General procedure for the cyclisation reaction. Chloroform was filtered through basic aluminium 2 
oxide prior to usage. To a solution of the resorcinarene capsule I (11.1 mg, 1.67 μmol, 0.10 eq) in 3 
chloroform (200 μL) were added successively HCl stock solution in chloroform (0.50 μmol, 0.03 eq) and 4 
n-decane stock solution in chloroform (20 μL, 167 mmol/L, 3.34 μmol, 0.2 eq). Then additional 5 
chloroform was added to reach a total volume of 500 μL for the reaction mixture. After substrate (16.7 6 
μmol, 1.00 eq) was added, the reaction mixture was briefly agitated. An aliquot (approx. 10 μL) of the 7 
reaction mixture was diluted with 0.2 mL n-hexane and subjected to GC analysis (initial sample). 8 
Meanwhile, the reaction was kept at 30 °C. After the indicated time, the reactions were sampled as 9 
described above and analyzed by GC. Conversions and yields were calculated as described in our 10 
previous work.34 11 
Preparation and titration of HCl-concentrated chloroform solution. HCl-concentrated chloroform 12 
solution was prepared by passing HCl-gas (prepared by dropwise addition of concentrated H2SO4 to 13 
dry NaCl) through chloroform for ca. 30min. The concentration of HCl in chloroform was determined 14 
as follows: to a solution of phenol red in EtOH (0.002wt%, 2.5 mL) was added HCl-saturated chloroform 15 
(100 μL) via a microman M1 pipette equipped with plastic tips. Upon addition, the solution turned 16 
from yellow (neutral) to pink (acidic). The resulting solution was then titrated with 0.1 M ethanolic 17 
solution of triethylamine (NEt3). At the equivalence point, the solution turned from pink to yellow.  18 
Computational method. Localization of stationary points and their characterization as minima (no 19 
imaginary frequency) or as transition structures (one imaginary frequency) was performed using 20 
GAUSSIAN16 (A.03)46 with the B3LYP/6-311+G(d,p)52 method including Grimme’s dispersion with 21 
Becke-Johnson damping.53 For all localized species, mPW1PW91/6-311+G(d,p)//B3LYP/6-311+G(d,p)-22 
GD3BJ54 single point computations provided electronic energies. The suitability of mPW1PW91//B3LYP 23 
computations for carbocation rearrangements was demonstrated recently.44, 45 Intrinsic reaction 24 
coordinate computations (IRC) were performed for all transition structures to verify correct 25 
interconnections with their related reactants and products. 26 
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